SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/22 FSD Pharma Inc. 20-F 12/31/21 132:39M Newsfile Corp./FA |
Document/Exhibit Description Pages Size 1: 20-F Annual or Annual-Transition Report by a Foreign HTML 2.06M Non-Canadian Issuer -- form20f 2: EX-1.1 Underwriting Agreement or Conflict Minerals Report HTML 43K -- exhibit1-1 3: EX-2.1 Plan of Acquisition, Reorganization, Arrangement, HTML 58K Liquidation or Succession -- exhibit2-1 9: EX-4.10 Instrument Defining the Rights of Security Holders HTML 35K -- exhibit4-10 10: EX-4.11 Instrument Defining the Rights of Security Holders HTML 36K -- exhibit4-11 11: EX-4.12 Instrument Defining the Rights of Security Holders HTML 34K -- exhibit4-12 12: EX-4.14 Instrument Defining the Rights of Security Holders HTML 70K -- exhibit4-14 13: EX-4.15 Instrument Defining the Rights of Security Holders HTML 78K -- exhibit4-15 14: EX-4.16 Instrument Defining the Rights of Security Holders HTML 82K -- exhibit4-16 15: EX-4.17 Instrument Defining the Rights of Security Holders HTML 82K -- exhibit4-17 4: EX-4.2 Instrument Defining the Rights of Security Holders HTML 251K -- exhibit4-2 5: EX-4.4 Instrument Defining the Rights of Security Holders HTML 33K -- exhibit4-4 6: EX-4.5 Instrument Defining the Rights of Security Holders HTML 75K -- exhibit4-5 7: EX-4.6 Exhibit44.6 HTML 36K 8: EX-4.9 Instrument Defining the Rights of Security Holders HTML 41K -- exhibit4-9 16: EX-8.1 Opinion of Counsel re: Tax Matters -- exhibit8-1 HTML 33K 19: EX-13.1 Annual or Quarterly Report to Security Holders -- HTML 35K exhibit13-1 20: EX-13.2 Annual or Quarterly Report to Security Holders -- HTML 35K exhibit13-2 22: EX-99.1 Miscellaneous Exhibit -- exhibit99-1 HTML 34K 17: EX-12.1 Statement re: the Computation of Ratios -- HTML 37K exhibit12-1 18: EX-12.2 Statement re: the Computation of Ratios -- HTML 37K exhibit12-2 21: EX-15.1 Letter re: Unaudited Interim Financial Info -- HTML 359K exhibit15-1 28: R1 Document And Entity Information HTML 116K 29: R2 Consolidated Statements of Financial Position HTML 107K 30: R3 Consolidated Statements of Loss and Comprehensive HTML 91K Loss 31: R4 Consolidated Statements of Changes in HTML 87K Shareholder's Equity 32: R5 Consolidated Statements of Cash Flows HTML 116K 33: R6 Nature of business HTML 48K 34: R7 Basis of presentation HTML 53K 35: R8 Significant accounting policies HTML 81K 36: R9 Acquisition of Prismic HTML 49K 37: R10 Acquisition of Lucid HTML 50K 38: R11 Assets held for sale HTML 99K 39: R12 Other receivables HTML 42K 40: R13 Prepaid expenses and deposits HTML 42K 41: R14 Investments HTML 95K 42: R15 Right-of-use asset HTML 43K 43: R16 Intangible assets HTML 50K 44: R17 Trade and other payables HTML 51K 45: R18 Notes payable HTML 43K 46: R19 Lease obligations HTML 52K 47: R20 Warrants Liability HTML 39K 48: R21 Share capital HTML 169K 49: R22 Share-based compensation HTML 231K 50: R23 Loss per share HTML 44K 51: R24 General and administrative HTML 53K 52: R25 Income Taxes HTML 66K 53: R26 Commitments and contingencies HTML 56K 54: R27 Related party transactions HTML 48K 55: R28 Capital Management HTML 38K 56: R29 Financial Instruments and Risk Management HTML 45K 57: R30 Segmented information HTML 37K 58: R31 Subsequent events HTML 38K 59: R32 Significant accounting policies (Policies) HTML 109K 60: R33 Nature of business (Tables) HTML 43K 61: R34 Significant accounting policies (Tables) HTML 40K 62: R35 Acquisition of Prismic (Tables) HTML 49K 63: R36 Acquisition of Lucid (Tables) HTML 48K 64: R37 Assets held for sale (Tables) HTML 97K 65: R38 Other receivables (Tables) HTML 42K 66: R39 Prepaid expenses and deposits (Tables) HTML 42K 67: R40 Investments (Tables) HTML 85K 68: R41 Right-of-use asset (Tables) HTML 42K 69: R42 Intangible assets (Tables) HTML 48K 70: R43 Trade and other payables (Tables) HTML 52K 71: R44 Notes Payable (Tables) HTML 41K 72: R45 Lease obligations (Tables) HTML 53K 73: R46 Share capital (Tables) HTML 159K 74: R47 Share-based compensation (Tables) HTML 234K 75: R48 Loss per share (Tables) HTML 43K 76: R49 General and administrative (Tables) HTML 52K 77: R50 Income Taxes (Tables) HTML 69K 78: R51 Related party transactions (Tables) HTML 43K 79: R52 Nature of business - Schedule of ownership HTML 51K percentage in subsidiaries (Details) 80: R53 Significant accounting policies - Schedule of HTML 55K estimated useful lives of assets (Details) 81: R54 Acquisition of Prismic (Narrative) (Details) HTML 51K 82: R55 Acquisition of Prismic - Schedule of black scholes HTML 78K options pricing model (Details) 83: R56 Acquisition of Prismic - Schedule of identifiable HTML 50K assets acquired and liabilities assumed (Details) 84: R57 Acquisition of Lucid (Narrative) (Details) HTML 56K 85: R58 Acquisition of Lucid - Schedule of Black Scholes HTML 77K options pricing model (Details) 86: R59 Acquisition of Lucid - Schedule of identifiable HTML 49K assets acquired and liabilities assumed (Details) 87: R60 Assets held for sale (Narrative) (Details) HTML 52K 88: R61 Assets held for sale - Schedule of components of HTML 39K assets held for sale (Details) 89: R62 Assets held for sale - Schedule of net loss and HTML 77K comprehensive loss from discontinued operations (Details) 90: R63 Assets held for sale - Schedule of cash flows from HTML 75K discontinued operations (Details) 91: R64 Other receivables - Schedule of other receivables HTML 42K (Details) 92: R65 Prepaid expenses and deposits - Schedule of HTML 42K prepaid expenses and deposits (Details) 93: R66 Investments (Narrative) (Details) HTML 206K 94: R67 Investments - Schedule of investments (Details) HTML 91K 95: R68 Right-of-use asset (Narrative) (Details) HTML 39K 96: R69 Right-of-use asset - Schedule of right-of-use HTML 45K asset (Details) 97: R70 Intangible assets (Narrative) (Details) HTML 52K 98: R71 Intangible assets - Schedule of intangible assets HTML 53K (Details) 99: R72 Trade and other payables - Schedule of trade and HTML 43K other payables (Details) 100: R73 Trade and other payables - Schedule of accrued HTML 47K liabilities (Details) 101: R74 Notes Payable (Narrative) (Details) HTML 51K 102: R75 Notes Payable - Schedule of notes payable HTML 42K (Details) 103: R76 Lease obligations - Schedule of lease obligations HTML 49K (Details) 104: R77 Lease obligations - Schedule of maturity analysis HTML 48K of operating lease payments (Details) 105: R78 Warrants Liability (Narrative) (Details) HTML 72K 106: R79 Share capital (Narrative) (Details) HTML 279K 107: R80 Share capital - Schedule of reconciliation of the HTML 89K share capital (Details) 108: R81 Share capital - Schedule of changes in number of HTML 50K warrants outstanding (Details) 109: R82 Share capital - Schedule of fair value assumptions HTML 52K of warrants (Details) 110: R83 Share capital - Schedule of warrants outstanding HTML 95K and exercise price (Details) 111: R84 Share-based compensation (Narrative) (Details) HTML 67K 112: R85 Share-based compensation - Schedule of changes in HTML 70K number of share options (Details) 113: R86 Share-based compensation - Schedule of fair value HTML 57K assumptions of share options granted (Details) 114: R87 Share-based compensation - Schedule of exercise HTML 216K price and weighted average contractual term of share options outstanding and exercisable (Details) 115: R88 Share-based compensation - Schedule of share-based HTML 47K compensation (Details) 116: R89 Loss per share - Schedule of loss per share HTML 44K (Details) 117: R90 General and administrative - Schedule of general HTML 57K and administrative expense (Details) 118: R91 Income Taxes (Narrative) (Details) HTML 41K 119: R92 Income Taxes - Schedule of provision for income HTML 53K taxes (Details) 120: R93 Income Taxes - Schedule of deferred tax assets HTML 40K (Liabilities) (Details) 121: R94 Income Taxes - Schedule of temporary differences HTML 52K for which deferred tax assets not recognised (Details) 122: R95 Income Taxes - Schedule of non-capital loss HTML 43K carryforwards (Details) 123: R96 Commitments and contingencies (Narrative) HTML 92K (Details) 124: R97 Related party transactions (Narrative) (Details) HTML 82K 125: R98 Related party transactions - Schedule of key HTML 42K management personnel compensation (Details) 126: R99 Capital management (Narrative) (Details) HTML 36K 127: R100 Subsequent events (Narrative) (Details) HTML 47K 130: XML IDEA XML File -- Filing Summary XML 223K 128: XML XBRL Instance -- form20f_htm XML 3.44M 129: EXCEL IDEA Workbook of Financial Reports XLSX 159K 24: EX-101.CAL XBRL Calculations -- huge-20211231_cal XML 183K 25: EX-101.DEF XBRL Definitions -- huge-20211231_def XML 1.17M 26: EX-101.LAB XBRL Labels -- huge-20211231_lab XML 4.85M 27: EX-101.PRE XBRL Presentations -- huge-20211231_pre XML 1.53M 23: EX-101.SCH XBRL Schema -- huge-20211231 XSD 613K 131: JSON XBRL Instance as JSON Data -- MetaLinks 490± 687K 132: ZIP XBRL Zipped Folder -- 0001062993-22-009034-xbrl Zip 657K
FSD Pharma Inc.: Exhibit 1.1 - Filed by newsfilecorp.com |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/02/24 FSD Pharma Inc. 20-F 12/31/23 120:15M Blueprint/FA 3/31/23 FSD Pharma Inc. 20-F 12/31/22 119:14M Newsfile Corp./FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/21/21 FSD Pharma Inc. 6-K 9/21/21 4:674K Business Wire/FA 5/05/21 FSD Pharma Inc. 6-K 5/14/21 3:914K Newsfile Corp./FA 2/11/21 FSD Pharma Inc. 6-K 2/11/21 2:217K Newsfile Corp./FA 3/18/20 FSD Pharma Inc. 6-K 3/18/20 2:17M Newsfile Corp./FA 12/06/19 FSD Pharma Inc. 40FR12B 52:25M Newsfile Corp./FA |